Remimazolam
44
7
7
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 44 trials
100.0%
+13.5% vs benchmark
27%
12 trials in Phase 3/4
0%
0 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (44)
Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy
Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia
Remimazolam on the Incidence of Postoperative Acute Kidney Injury
Patient-controlled Remimazolam Sedation Under Spinal Anesthesia
Remimazolam TIVA-Flumazenil Antagonism in Short-duration ENT Surgeries
Remimazolam NeuroImaging
The Effect of Reversal of Remimazolam Sedation With Flumazenil on Cognitive Function in Patients Undergoing Hip Arthroplasty Under Spinal Anesthesia
Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Minimally Invasive AVR
Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
Remimazolam and Emergence Delirium in Pediatrics
Comparison in Frequency of Hypotension Between Remimazolam and Propofol in Hip Surgery
Remimazolam Besylate in Sedation of Postcardioperative Patients
The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function
The EEG Study Under Remimazolam Anesthesia in Children
RCT Comparing Remimazolam With Propofol Under EEG DSA Guidance During Cardiac Electrophysiology Studies and Ablation
Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation
Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients
The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate